GlassScriptPhysician profile
Matthew H Kalter
NPI 1396751558
$5,272.55
in general payments reported to CMS, 2019-2025
17 companies · $94.79 in 2025
The $94.79 reported for 2025 was less than what a typical Pain Medicine (Physical Medicine & Rehabilitation) provider received nationally (typical 2025 total: $400).
See the full distribution for Pain Medicine (Physical Medicine & Rehabilitation)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,268 · 2020: $114 · 2021: $1,745 · 2022: $472 · 2023: $236 · 2024: $343 · 2025: $94.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $673.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $673.20 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic USA, INC. | $2,090.00 | 2019 | |
| Medtronic, INC. | $866.17 | 2021-2024 | Intellis Adaptivestim, Micra, Vanta Adaptivestim |
| Relievant Medsystems, INC. | $782.44 | 2021-2022 | |
| Horizon Therapeutics Plc | $403.85 | 2019-2022 | |
| Depuy Synthes Sales INC. | $238.32 | 2019-2025 | Orthovisc, Monovisc |
| Abbott Laboratories | $188.01 | 2023-2025 | Proclaim |
| Vertos Medical, INC. | $173.61 | 2021 | |
| Collegium Pharmaceutical, INC. | $118.25 | 2020-2023 | Xtampza |
| Redhill Biopharma INC. | $115.78 | 2020-2022 | |
| Spinal Simplicity, LLC | $48.50 | 2025 | Ha Minuteman G3-R |
| Boston Scientific Corporation | $47.24 | 2022-2024 | Intracept |
| Forte Bio-Pharma LLC | $44.82 | 2023 | Prolate, Nalocet |
| Scilex Pharmaceuticals INC. | $42.64 | 2019-2022 | |
| Virtus Pharmaceuticals LLC | $40.65 | 2021 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $30.00 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Valinor Pharma, LLC | $27.56 | 2023 | Movantik |
| Allergan, INC. | $14.71 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Kalter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.